Bimagrumab (Anti-ACVR2B)
Bimagrumab (Anti-ACVR2B) (A2595-GRP)
Products
Description
Bimagrumab (Anti-ACVR2B) is a human monoclonal antibody targeting activin type II receptor (ActRII). It can be used for the treatment of pathological muscle loss and weakness. MW : 150 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2595 |